Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study

INTRODUCTION: Molecular markers that predict responses to particular therapies are invaluable for optimization of patient treatment. The TRYPHAENA study showed that pertuzumab and trastuzumab with chemotherapy was an efficacious and tolerable combination for patients with human epidermal growth fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneeweiss, Andreas, Chia, Stephen, Hegg, Roberto, Tausch, Christoph, Deb, Rahul, Ratnayake, Jayantha, McNally, Virginia, Ross, Graham, Kiermaier, Astrid, Cortés, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226982/
https://www.ncbi.nlm.nih.gov/pubmed/25005255
http://dx.doi.org/10.1186/bcr3690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226982/
https://www.ncbi.nlm.nih.gov/pubmed/25005255
http://dx.doi.org/10.1186/bcr3690

Ejemplares similares